Bivalent bendamustine and melphalan derivatives as anticancer agents.


:The alkylating agents bendamustine and melphalan are currently used in the treatment of various tumoral diseases. In order to increase their antitumor potency and tumor selectivity both compounds were integrated in structure-activity relationship studies including new drug carrier systems. Here we describe the synthesis and the cytotoxicity of new bivalent bendamustine and melphalan derivatives. Two molecules each esterified with N-(2-hydroxyethyl)maleimide were connected by diamines with various chain lengths (n=6, 7, 8, 12). It was supposed that these conjugates (5a-d, 10a-d, 11a-d) cause cytotoxic effects preferred as bivalent drug. Indeed the cytotoxicity of the new compounds increased compared to bendamustine and melphalan as determined in concentration-dependent in vitro assays using the human MCF-7 and MDA-MB-231 breast cancer cell lines.


Eur J Med Chem


Scutaru AM,Wenzel M,Gust R




Has Abstract


2011-05-01 00:00:00














  • Benzo[d]thiazol-2(3H)-ones as new potent selective CB2 agonists with anti-inflammatory properties.

    abstract::The high distribution of CB2 receptors in immune cells suggests their important role in the control of inflammation. Growing evidence offers this receptor as an attractive therapeutic target: selective CB2 agonists are able to modulate inflammation without triggering psychotropic effects. In this work, we report a new...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Leleu-Chavain N,Baudelet D,Heloire VM,Rocha DE,Renault N,Barczyk A,Djouina M,Body-Malapel M,Carato P,Millet R

    更新日期:2019-03-01 00:00:00

  • Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model.

    abstract::We have designed and synthesized certain novel oxime- and amide-bearing coumarin derivatives as nuclear factor erythroid 2 p45-related factor 2 (Nrf2) activators. The potency of these compounds was measured by antioxidant responsive element (ARE)-driven luciferase activity, level of Nrf2-related cytoprotective genes a...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Chang KM,Chen HH,Wang TC,Chen IL,Chen YT,Yang SC,Chen YL,Chang HH,Huang CH,Chang JY,Shih C,Kuo CC,Tzeng CC

    更新日期:2015-12-01 00:00:00

  • Synthesis of C- and O-prenylated tetrahydroxystilbenes and O-prenylated cinnamates and their action towards cancer cells.

    abstract::Synthesis of the naturally occurred C- and O-prenylated tetrahydroxystilbenes and O-prenylated cinnamates was carried out by decarbonylative Heck reaction and selenium dioxide catalysed oxidation, respectively. In the decarbonylative Heck synthetic route, fusion of benzoyl chloride and styrene derivatives was catalyse...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Koolaji N,Abu-Mellal A,Tran VH,Duke RK,Duke CC

    更新日期:2013-05-01 00:00:00

  • Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.

    abstract::A series of multitarget ligands was designed by introducing several structurally diverse aminoacetamide groups at position 6 of the deoxyvasicinone group, with the aim of obtaining novel multifunctional anti-Alzheimer's disease agents using deoxyvasicinone as the substrate. In vitro studies showed that almost all of t...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Ma F,Du H

    更新日期:2017-11-10 00:00:00

  • Thioether-based 2-aminobenzamide derivatives: Novel HDAC inhibitors with potent in vitro and in vivo antitumor activity.

    abstract::Previously, we focused on a series of 2-aminobenzamide-based histone deacetylase (HDAC) inhibitors, compound 9 of which displayed potent HDAC inhibitory activity against HDAC1 and HDAC2, and moderate anti-proliferative activity against several cancer cell lines. In the current study, we have designed and synthesized a...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Yun F,Cheng C,Ullah S,He J,Zahi MR,Yuan Q

    更新日期:2019-08-15 00:00:00

  • Cytotoxic N-(fluorenyl-9-methoxycarbonyl) (Fmoc)-dipeptides: structure-activity relationships and synergistic studies.

    abstract::The synthesis and cytotoxic evaluation of a series of Fmoc-based dipeptides are described. Among the thirty compounds, 4a, 8a, 12a, 2b, 4b, 10b, 3c, 4c and 6c showed potent activity against HepG2, Hep3B, MCF-7, MDA-MB-231, A549 and Ca9-22 human cancer cell lines. The most active compounds (10a and 10c) showed relative...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Yen CT,Wu CC,Lee JC,Chen SL,Morris-Natschke SL,Hsieh PW,Wu YC

    更新日期:2010-06-01 00:00:00

  • PRODRUGS FOR NITROREDUCTASE BASED CANCER THERAPY- 2: Novel amide/Ntr combinations targeting PC3 cancer cells.

    abstract::The use of nitroreductases (NTR) that catalyze the reduction of nitro compounds by using NAD(P)H in GDEPT (Gene-directed enzyme prodrug therapy) studies which minimize toxicity at healthy cells and increases concentration of drugs at cancer cells is remarkable. Discovery of new prodrug/NTR combinations is necessary to...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Güngör T,Önder FC,Tokay E,Gülhan ÜG,Hacıoğlu N,Tok TT,Çelik A,Köçkar F,Ay M

    更新日期:2019-06-01 00:00:00

  • Single-molecule chemiluminescent photosensitizer for a self-activating and tumor-selective photodynamic therapy of cancer.

    abstract::While photodynamic therapy is known for significant advantages over conventional cancer therapies, its dependence on light has limited it to treating tumors on or just under the skin or on the outer lining of organs/cavities. Herein, we have developed a single-molecule photosensitizer capable of intracellular self-act...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Pinto da Silva L,Núnez-Montenegro A,Magalhães CM,Ferreira PJO,Duarte D,González-Berdullas P,Rodríguez-Borges JE,Vale N,Esteves da Silva JCG

    更新日期:2019-12-01 00:00:00

  • Dual-target kinase drug design: Current strategies and future directions in cancer therapy.

    abstract::Protein kinases are well-known to orchestrate the activation of signaling cascades in response to extracellular and intracellular stimuli to control cell proliferation and survival. The perturbation of such kinases by some mutation or abnormal protein expressions has been closely linked to cancer. Drug development aim...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章,评审


    authors: Sun D,Zhao Y,Zhang S,Zhang L,Liu B,Ouyang L

    更新日期:2020-02-15 00:00:00

  • Design, synthesis and biological evaluation of piperazinyl-β-carbolinederivatives as anti-leishmanial agents.

    abstract::Molecular hybridization is a ligand based drug design approach is well known recent medicinal chemistry to design anti-parasitic agents. In the present study, we have designed a series of (1-phenyl-9H-pyrido [3,4-b]indol-3-yl) (4-phenylpiperazin-1-yl)methanone derivatives using molecular hybridization approach. Design...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Ashok P,Chander S,Smith TK,Sankaranarayanan M

    更新日期:2018-04-25 00:00:00

  • New glycosidic derivatives of histidine-containing dipeptides with antioxidant properties and resistant to carnosinase activity.

    abstract::Synthesis, antioxidant properties and resistance to carnosinase hydrolysis of histidine-containing dipeptides are reported in this study. Carnosine (beta-alanyl-l-histidine), homocarnosine (gamma-aminobutyryl-l-histidine) and anserine (beta-alanyl-3-methyl-l-histidine) were covalently derivatized with beta-cyclodextri...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Bellia F,Amorini AM,La Mendola D,Vecchio G,Tavazzi B,Giardina B,Di Pietro V,Lazzarino G,Rizzarelli E

    更新日期:2008-02-01 00:00:00

  • Dimeric aryl-substituted imidazoles may inhibit ALT cancer by targeting the multimeric G-quadruplex in telomere.

    abstract::In 10-15% of cancers, telomere maintenance is provided by a telomerase-independent mechanism known as alternative lengthening of telomere (ALT), making telomerase inhibitors ineffective on these cancers. Ligands that stabilize telomeric G-quadruplex (G4) are considered to be able to inhibit either the ALT process or d...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Hu MH,Lin XT,Liu B,Tan JH

    更新日期:2020-01-15 00:00:00

  • Synthesis and biological evaluation of novel 2-aralkyl-5-substituted-6-(4'-fluorophenyl)-imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent anticancer agents.

    abstract::Levamisole, the imidazo[2,1-b]thiazole derivative has been reported as a potential antitumor agent. In the present study, we synthesized, characterized and evaluated biological activity of its novel analogues with substitution in the aralkyl group and on imidazothiadiazole molecules with same chemical backbone but dif...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Karki SS,Panjamurthy K,Kumar S,Nambiar M,Ramareddy SA,Chiruvella KK,Raghavan SC

    更新日期:2011-06-01 00:00:00

  • Identification and development of non-cytotoxic cell death modulators: Impact of sartans and derivatives on PPARγ activation and on growth of imatinib-resistant chronic myelogenous leukemia cells.

    abstract::4'-((2-Propyl-1H-benzo[d]imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid derived from telmisartan was identified as lead for the design of cell death modulators. In this study, we evaluated the efficacy of telmisartan itself and other sartans in combination with imatinib against K562-resistant cells. The findi...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Schoepf AM,Salcher S,Obexer P,Gust R

    更新日期:2020-06-01 00:00:00

  • NSAIDs revisited: putative molecular basis of their interactions with peroxisome proliferator-activated gamma receptor (PPARgamma).

    abstract::This paper describes molecular docking studies of a series of classical NSAIDs with PPARgamma receptor, which has been pointed as a new target for the design of anti-cancer and anti-inflammatory drugs, and has been found to be responsible for some of the already established pharmacological effects observed for markete...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Romeiro NC,Sant'Anna CM,Lima LM,Fraga CA,Barreiro EJ

    更新日期:2008-09-01 00:00:00

  • Synthesis and biological evaluation of geniposide derivatives as potent and selective PTPlB inhibitors.

    abstract::Herein a series of Geniposide derivatives were designed, synthesized and evaluated as protein tyrosine phosphatase 1B (PTPlB) inhibitors. Most of these compounds exhibited potent in vitro PTP1B inhibitory activities, the representative 7a and 17f were found to be the most potent inhibitors against the enzyme with IC50...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Lei S,Zhang D,Qi Y,Chowdhury SR,Sun R,Wang J,Du Y,Fu L,Jiang F

    更新日期:2020-11-01 00:00:00

  • Cyclooxygenase-1/2 (COX-1/COX-2) and 5-lipoxygenase (5-LOX) inhibitors of the 6,7-diaryl-2,3-1H-dihydropyrrolizine type.

    abstract::A series of 6,7-diaryl-2,3-1H-dihydropyrrolizines was prepared as COX-1/COX-2 and 5-LOX inhibitors. The inhibition of COX-1 was evaluated using intact bovine platelets as the enzyme source, whereas LPS-stimulated human monocytes served as the enzyme source for inducible COX-2. The determination of arachidonic metaboli...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Ulbrich H,Fiebich B,Dannhardt G

    更新日期:2002-12-01 00:00:00

  • Current research on hyaluronic acid-drug bioconjugates.

    abstract::Hyaluronic acid (HA) is a mucopolysaccharide acid composed of repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine. Based on numerous characteristics such as viscoelastic properties, water-binding ability, biocompatibility and non-immunogenicity, HA has been approved by FDA for biological and m...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章,评审


    authors: Zhang H,Huang S,Yang X,Zhai G

    更新日期:2014-10-30 00:00:00

  • Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.

    abstract::Natural pentacyclic triterpenoids (PTs) have been often reported to exhibit a wide range of biological activities. Among them, the anticancer and anti-inflammatory activities are the most studied. Over the last two decades, the number of publications reporting the anticancer effects of PTs has risen exponentially, ref...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章,评审


    authors: Salvador JAR,Leal AS,Valdeira AS,Gonçalves BMF,Alho DPS,Figueiredo SAC,Silvestre SM,Mendes VIS

    更新日期:2017-12-15 00:00:00

  • Design, synthesis, and in vitro cancer cell growth inhibition evaluation and antimalarial testing of trioxanes installed in cyclic 2-enoate substructures.

    abstract::A novel series of 1,2,4-trioxanes were synthesized from 2H-pyrans via photooxidation, and their antiproliferative and growth factor inhibitory activity has been investigated across a variety of human cancer cell lines. Compounds 5k, 5l, 5s, 7a and 7c exhibited the highest activity and selectivity against a human leuke...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Hossain MI,Świtalska M,Peng W,Takashima M,Wang N,Kaiser M,Wietrzyk J,Dan S,Yamori T,Inokuchi T

    更新日期:2013-11-01 00:00:00

  • Molecular structure of the NQTrp inhibitor with the Alzheimer Aβ1-28 monomer.

    abstract::The self-assembly of the amyloid-β (Aβ) peptide of various amino acid lengths into senile plaques is one hallmark of Alzheimer's disease pathology. In the past decade, many small molecules, including NQTrp, have been identified to reduce aggregation and toxicity. However, due to the heterogeneity of the conformational...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Tarus B,Nguyen PH,Berthoumieu O,Faller P,Doig AJ,Derreumaux P

    更新日期:2015-02-16 00:00:00

  • Design, synthesis and biological evaluation of novel 4-thiazolidinones containing indolin-2-one moiety as potential antitumor agent.

    abstract::A series of novel 4-thiazolidinone and indolin-2-one hybrid derivatives 5a-5s and 10a-10s have been designed and synthesized and their cytotoxic activities were evaluated in vitro against three human cancer cell lines including HT-29 (human colon cancer), H460 (human lung cancer), MDA-MB-231 (human breast cancer) by M...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Wang S,Zhao Y,Zhang G,Lv Y,Zhang N,Gong P

    更新日期:2011-08-01 00:00:00

  • Design, synthesis and biological evaluation of novel N-[4-(2-fluorophenoxy)pyridin-2-yl]cyclopropanecarboxamide derivatives as potential c-Met kinase inhibitors.

    abstract::Three series of novel 4-phenoxypyridine derivatives containing 4-methyl-6-oxo-1,6-dihydropyridazine- 3-carboxamide, 5-methyl-4-oxo-1,4-dihydropyridazine-3-carboxamide and 4-methyl-3,5-dioxo-2,3,4,5- tetrahydro-1,2,4-triazine-6-carboxamide moieties were synthesized and evaluated for their in vitro inhibitory activitive...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Liu J,Gong Y,Shi J,Hao X,Wang Y,Zhou Y,Hou Y,Liu Y,Ding S,Chen Y

    更新日期:2020-05-15 00:00:00

  • Discovery of 5-bromo-4-phenoxy-N-phenylpyrimidin-2-amine derivatives as novel ULK1 inhibitors that block autophagy and induce apoptosis in non-small cell lung cancer.

    abstract::UNC51-like kinase1 (ULK1) recruits its binding partners and initiates the autophagy process in cancer. ULK1 is significantly overexpressed in Non-small cell lung cancer (NSCLC) and negatively correlated with clinical prognosis in NSCLC patients. Based upon the binding features of ULK1, we explored the pharmacophore mo...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Sun D,Yang Z,Zhen Y,Yang Y,Chen Y,Yuan Y,Zhang L,Zeng X,Chen L

    更新日期:2020-12-15 00:00:00

  • Lipid lowering agents of natural origin: An account of some promising chemotypes.

    abstract::The role of natural products in the drug development and discovery has been phenomenal. There has been an enormous interest in exploring all possible natural sources to identify structures exhibiting pronounced hypolipidemic activity albeit with no toxicity. The present review describes the profile of some interesting...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章,评审


    authors: Singh SP,Sashidhara KV

    更新日期:2017-11-10 00:00:00

  • New chromene scaffolds for adenosine A(2A) receptors: synthesis, pharmacology and structure-activity relationships.

    abstract::In silico screening of a collection of 1584 academic compounds identified a small molecule hit for the human adenosine A(2A) receptor (pK(i) = 6.2) containing a novel chromene scaffold (3a). To explore the structure-activity relationships of this new chemical series for adenosine receptors, a focused library of 43 2H-...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Areias F,Costa M,Castro M,Brea J,Gregori-Puigjané E,Proença MF,Mestres J,Loza MI

    更新日期:2012-08-01 00:00:00

  • Design, synthesis, in vitro antiproliferative evaluation, and kinase inhibitory effects of a new series of imidazo[2,1-b]thiazole derivatives.

    abstract::Design and synthesis of a new series of 5,6-diarylimidazo[2,1-b]thiazole derivatives possessing terminal aryl sulfonamide moiety are described. Their in vitro antiproliferative activities against a panel of 57 human cancer cell lines of nine different cancer types were tested at the NCI. Compounds 8a, 8b, 8n, 8q, 8t, ...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Abdel-Maksoud MS,Kim MR,El-Gamal MI,Gamal El-Din MM,Tae J,Choi HS,Lee KT,Yoo KH,Oh CH

    更新日期:2015-05-05 00:00:00

  • New synthesis of 3-(β-D-glucopyranosyl)-5-substituted-1,2,4-triazoles, nanomolar inhibitors of glycogen phosphorylase.

    abstract::O-Perbenzoylated 5-(β-D-glucopyranosyl)tetrazole was reacted with N-benzyl carboximidoyl chlorides to give the corresponding 4-benzyl-3-(β-D-glucopyranosyl)-5-substituted-1,2,4-triazoles. Removal of the O-benzoyl and N-benzyl protecting groups by base catalysed transesterification and catalytic hydrogenation, respecti...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Kun S,Bokor É,Varga G,Szőcs B,Páhi A,Czifrák K,Tóth M,Juhász L,Docsa T,Gergely P,Somsák L

    更新日期:2014-04-09 00:00:00

  • Design, synthesis, and fungicidal evaluation of a series of novel 5-methyl-1H-1,2,3-trizole-4-carboxyl amide and ester analogues.

    abstract::Succinate dehydrogenase inhibitors (SDHIs) are efficient fungicides that are widely used to control plant diseases caused by phytopathogenic fungi, although their effectiveness is undermined by the development of resistance across a range of different fungi. One of the most common structural features of SDHIs is their...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Wang ZJ,Gao Y,Hou YL,Zhang C,Yu SJ,Bian Q,Li ZM,Zhao WG

    更新日期:2014-10-30 00:00:00

  • An orally available inverse agonist of estrogen-related receptor gamma showed expanded efficacy for the radioiodine therapy of poorly differentiated thyroid cancer.

    abstract::Estrogen-related receptor gamma (ERRγ) is the NR3B subgroup of associated transcription factors. In this report, a new generation of a potent and selective ERRγ inverse agonist (25) with good biocompatibility was proposed. We also explored the potential of the newly developed compound 25 in the PDTC model to expand th...

    journal_title:European journal of medicinal chemistry

    pub_type: 杂志文章


    authors: Kim J,Hwang H,Yoon H,Lee JE,Oh JM,An H,Ji HD,Lee S,Cha E,Ma MJ,Kim DS,Lee SJ,Kadayat TM,Song J,Lee SW,Jeon JH,Park KG,Lee IK,Jeon YH,Chin J,Cho SJ

    更新日期:2020-11-01 00:00:00